Donor Login
Contact Us
JDRF
About
Investment Strategy
Portfolio
Our People
Venture Philanthropy
News
Donor Login
Get in touch
News and Press
Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development
April 06, 2022 |
Boston, MA
SQZ Biotechnologies Publishes Comprehensive Preclinical Research on SQZ® TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
April 04, 2022 |
WATERTOWN, Mass.
Jaguar Gene Therapy Announces Samsung and JDRF T1D Fund as New Investors
March 29, 2022 |
LAKE FOREST, Ill.
Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial
March 15, 2022 |
MONTREAL (CANADA)
Code Biotherapeutics Announces Collaboration with Takeda to Use Proprietary 3DNA Genetic Medicine Delivery Platform to Design and Develop Gene Therapies for Rare Diseases
February 22, 2022 |
Greater Philadelphia, Pa.